Announcement as per Reg 30-Letter of Offer

Open Offer TriggeredListed Co AcquisitionStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹65.14

prior close

₹68.39

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.1%+2.0% vs market

Healthcare Service Provider peers, median of 22sector-0.4%+1.2% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.2 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.2

15m

-0.2

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9-1.1+2.0-0.4+1.2

Next day

+0.6-0.1+0.7-0.4+0.9

+2.0+0.4+1.7-0.5+2.6

+2.8-0.1+2.9-1.8+4.6

+0.0+0.9-0.9-1.1+1.1

-2.3+1.9-4.3-0.6-1.8

-1.4+1.1-2.4-2.1+0.7

15d

-7.9+0.2-8.1-4.2-3.7

-7.2+0.7-7.9-2.2-5.0

+2.8-4.0+6.7-9.8+12.6

-1.6-7.0+5.4-7.2+5.6

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aspira Pathlab & Diagnostics has informed BSE that it has received the Letter of Offer for an Open Offer made by five acquirers — Arvind Karsandas Bhanushali, Deepali Arvind Bhanushali, Jay Arvind Bhanushali, Nikunj Velji Mange, and Raj Arvind Bhanushali — along with PAC Shraddha Nikunj Mange. The offer is for up to 26,76,180 equity shares (26% of voting capital) at ₹55 per share, totalling about ₹14.72 crore. It is a triggered open offer under SEBI Takeover Regulations, linked to a change in control of the company. After the offer, the acquirers together with the PAC will hold 49.82% of the voting share capital. The tendering period runs from November 24, 2025 to December 5, 2025, with payment expected within 10 working days of closure.

Likely market impact

Public shareholders can choose to tender their shares at ₹55 during the tendering window. The offer signals a change in control at Aspira Pathlab, with the acquirer group crossing the 49.82% mark, which may influence the stock price and prompt shareholders to evaluate whether to hold or exit at the offer price.